Evaluation of the EPDS and PC-PTSD-5 Scales for Screening Postpartum Mental Health Disorders Among Migrant Women.
Key facts
- Who runs it
- Fondation Hôpital Saint-Joseph
- Where
- France and French Guiana3 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 80 people, planned
- Starts
- Dec 2026
- Expected to end
- Dec 2027
- Type of study
- Interventional
- Treatments tested
- psychiatric interview
- Record updated
- 10 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Adult woman (≥18 years old) Having delivered in one of the three participating centers during the inclusion period Migrant woman: born abroad, holding a foreign nationality, and delivering in France for the Paris Saint-Joseph and Montreuil sites Migrant woman (born abroad with a foreign nationality) or native woman (born in French Guiana) for the Cayenne site Covered or not covered by a health insurance scheme (see rationale in Appendix 3) French-speaking or non-French-speaking (non-French-speaking women may be included with the assistance of a professional interpreter or intercultural mediator) Having provided free, informed, and explicit oral consent to participate in the study
Who cannot take part
- dentified personal psychiatric history (major depressive disorder, bipolar disorder, psychotic disorder, or diagnosed PTSD), documented in the medical record or self-reported during the inclusion interview; current psychotropic medication use; or a psychiatric disorder diagnosed during the postpartum maternity stay prior to discharge Participation in another interventional research study classified as RIPH1 Individuals subject to a legal protection measure (safeguard of justice, guardianship, or curatorship) Individuals deprived of their liberty
This trial has no sites in United States.
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
Postpartum depression (affecting approximately 15% of women) and childbirth-related post-traumatic stress disorder (PTSD) (affecting approximately 5%) are major public health concerns due to their frequency and their impact on both maternal and child health. Diagnosis relies on specialized clinical interviews, which are difficult to offer systematically to all women after childbirth. Consequently, self-report screening tools are widely used, particularly the Edinburgh Postnatal Depression Scale (EPDS) for postpartum depression and the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) for PTSD.
Read full original descriptionShow less
However, these tools were developed and validated in the general population and may be less suitable for certain groups, particularly migrant women, who are at increased risk of postpartum mental health disorders. Their migration experiences are sometimes marked by traumatic events, which may contribute to complex forms of PTSD, and their clinical presentations may differ from those typically observed. Certain culturally specific expressions of psychological distress, dissociative symptoms, or somatic manifestations are not captured by current screening questionnaires.
Furthermore, cultural differences, perceptions of mental health, and language barriers may complicate the psychological assessment of these women and influence their responses to screening tools. These specific factors suggest that existing questionnaires may have insufficient diagnostic performance in some groups of migrant women.
The Psy4Mums project therefore aims to assess the relevance and performance of these screening tools in migrant populations that are particularly vulnerable from psychological, social, and economic perspectives. This evaluation may, if necessary, lead to adaptations in their content, cutoff scores, or methods of administration in order to improve the identification of postpartum mental health disorders. This approach is especially important in French Guiana, where more than half of all women giving birth are migrants.
The group in the trial
- psychatric interviewTreatment being tested
Treatment: psychiatric interview
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 10 November 2026